logo
  • About
  • R&D
  • Pipeline
  • Investors
  • News
  • Contact
  • Primary Sclerosing Cholangitis
  • Nonalcoholic Steatohepatitis (NASH)
  • (NASH) דלקת כבד על רקע שומני
Investor Relations

Investor Relations

  • Overview
  • News & Events
    • News
    • Events
    • Presentations
    • Contact IR
    • Email Alerts
  • Financials & Filings
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • Stock
    • Stock Quote & Chart
    • Historical Stock Price
    • Analyst Coverage
  • Corporate Governance
    • Board Committees
    • Board of Directors
    • Leadership
    • Documents
    • SEC Filings

    • Annual Reports

    • Quarterly Results

SEC Filings

NASDAQCMMB
YearTrailing 12-MonthsCalendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2013Calendar Year 2012Calendar Year 2011
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Mergers & AcquisitionsProxy & Information StatementsOther
FormDescriptionDateFormat
20-FRegistration of securities of foreign private issuers pursuant to section 12(b) or (g)Apr 23, 2013Open Registration of securities of foreign private issuers pursuant to section 12(b) or (g) in HTML.Open Registration of securities of foreign private issuers pursuant to section 12(b) or (g) in DOC file.Open Registration of securities of foreign private issuers pursuant to section 12(b) or (g) in PDF file.Open Registration of securities of foreign private issuers pursuant to section 12(b) or (g) in XLS file.
SC 13D/AAmendment to a SC 13D filingJan 8, 2013Open Amendment to a SC 13D filing in HTML.Open Amendment to a SC 13D filing in DOC file.Open Amendment to a SC 13D filing in PDF file.Open Amendment to a SC 13D filing in XLS file.
15-15DCertification of Termination of Registration Jan 2, 2013Open Certification of Termination of Registration in HTML.Open Certification of Termination of Registration in DOC file.Open Certification of Termination of Registration in PDF file.Open Certification of Termination of Registration in XLS file.

Investor Relations

Chemomab Therapeutics Ltd.

Kiryat Atidim, Building 7
Tel Aviv, Israel 6158002

Follow us on

Subscribe to Alerts

Irina Koffler

LifeSci Advisors, LLC

IR@Chemomab.com

Phone: +1-917-734-7387

Barbara Lindheim

Consulting Vice President

Investor & Public Relations

barbara@chemomab.com

Phone: +1-917-355-9234

Copyright © Chemomab. All rights reserved.

Privacy Policy Terms of Service

Designed and built by Studio Praktik